Lavine Steven J
Department of Medicine, Division of Cardiology, Wayne State University and University of Florida/Jacksonville, Detroit, Michigan and Jacksonville, Florida, USA.
Cardiovasc Ultrasound. 2006 Nov 17;4:45. doi: 10.1186/1476-7120-4-45.
The index of myocardial performance has prognostic power in patients with cardiomyopathy and following myocardial infarction. As the index of myocardial performance has been shown to be preload and afterload dependent, the effect of altering contractility on IMP and its components with left ventricular dysfunction has been incompletely delineated.
Chronic left ventricular dysfunction was induced in 10 canines using coronary microsphere embolization. Each dog was instrumented and imaged with 2D echo and Doppler. At the same atrially paced rate, contractility was increased with a dobutamine infusion and then following 4 weeks of oral digoxin.
With chronic left ventricular dysfunction, a reduced left ventricular ejection fraction (42 +/- 3%, p < 0.001) and increased index of myocardial performance (0.58 +/- 0.17, p < 0.01) due to isovolumic contraction time lengthening and shortened left ventricular ejection time were noted. Dobutamine increased ejection fraction (p < 0.001), reduced left ventricular end diastolic pressure (p < 0.01), and reduced the index of myocardial performance (0.33 +/- 0.17, p < 0.001) due to isovolumic contraction time, isovolumic relaxation time, and left ventricular ejection time shortening. Digoxin increased ejection fraction (p < 0.05), reduced left ventricular end diastolic pressure (p < 0.05), and reduced the index of myocardial performance (0.42 +/- 0.13, p < 0.01) due to isovolumic contraction time shortening (p < 0.001). Both dobutamine and digoxin lengthened the diastolic filling period (p < 0.01).
Increased inotropy with digoxin and dobutamine reduced the index of myocardial performance in dogs with left ventricular dysfunction. Shortened isovolumic contraction time, increased diastolic filling period, and reduced left ventricular end diastolic pressure with digoxin may provide insight into its efficacy in heart failure.
心肌性能指数对心肌病患者及心肌梗死后患者具有预后评估价值。由于心肌性能指数已被证明依赖前负荷和后负荷,因此在左心室功能不全的情况下,改变收缩性对心肌性能指数及其组成部分的影响尚未完全阐明。
使用冠状动脉微球栓塞法在10只犬中诱发慢性左心室功能不全。每只犬均通过二维超声心动图和多普勒进行仪器检测和成像。在相同的心房起搏频率下,通过静脉输注多巴酚丁胺增加收缩性,随后口服地高辛4周。
在慢性左心室功能不全的情况下,由于等容收缩时间延长和左心室射血时间缩短,左心室射血分数降低(42±3%,p<0.001),心肌性能指数增加(0.58±0.17,p<0.01)。多巴酚丁胺增加了射血分数(p<0.001),降低了左心室舒张末期压力(p<0.01),并由于等容收缩时间、等容舒张时间和左心室射血时间缩短而降低了心肌性能指数(0.33±0.17,p<0.001)。地高辛增加了射血分数(p<0.05),降低了左心室舒张末期压力(p<0.05),并由于等容收缩时间缩短(p<0.001)而降低了心肌性能指数(0.42±0.13,p<0.01)。多巴酚丁胺和地高辛均延长了舒张充盈期(p<0.01)。
地高辛和多巴酚丁胺增加心肌收缩力降低了左心室功能不全犬的心肌性能指数。地高辛缩短等容收缩时间、增加舒张充盈期并降低左心室舒张末期压力,这可能有助于深入了解其在心力衰竭中的疗效。